Under ‐utilisation of high‐dose‐rate brachytherapy boost in men with intermediate‐high risk prostate cancer treated with external beam radiotherapy

ConclusionHigh‐dose‐rate brachytherapy is under‐utilised with EBRT in this contemporary population‐based cohort of Victorian men with CaP. The decline in HDR‐BT use was also observed nationally.

Source: Australasian Radiology - December 22, 2017 Category: Radiology Authors: Wee Loon Ong, Sue M Evans, Jeremy L Millar Tags: Radiation Oncology —Original Article Source Type: research